Print Print

Client Spotlight | Ampio Pharmaceuticals, Inc.


EKS&H is proud to serve the audit and tax needs of Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company.


“Bioscience is a critical industry in Colorado, and we are proud to work with an industry-leading company like Ampio,” says EKS&H Partner Sandy Shoemaker.

Focused on novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options, Ampio Pharmaceuticals, Inc., research helps patients with metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction, and CNS disease.

circular rack of analysis test tubes, green liquid 2x2

Central to the company’s successful clinical development programs are its strong relationships with clinicians, academic medical centers, regional hospitals, and specialized product and service providers. A Phase II clinical development program is under way as are sponsored basic, translational, and clinical research projects aimed at specific disease mechanisms. The company has built a robust portfolio of issued patents and pending patent applications on its products.

A key strategy includes actively exploring partnership, licensing, and other collaboration opportunities that will maximize the potential value of the company’s product development programs.

For more information about Ampio Pharmaceuticals, Inc., please visit